Conventional disease-modifying antirheumatic drugs therapy may not slow spinal radiographic progression in ankylosing spondylitis: results from an 18-year longitudinal dataset

OBJECTIVES: The clinical benefit of conventional disease-modifying antirheumatic drugs (cDMARDs) for treating ankylosing spondylitis (AS) is generally limited to improvements in peripheral arthritis. However, cDMARDs could be conditionally considered as alternatives to established drugs for improvin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Musculoskelet Dis
Main Authors: Lee, Tae-Han, Koo, Bon San, Nam, Bora, Oh, Ji Seon, Park, Seo Young, Lee, Seunghun, Joo, Kyung Bin, Kim, Tae-Hwan
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705797/
https://ncbi.nlm.nih.gov/pubmed/33294039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20975912
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados